These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 15252821

  • 21. CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response.
    Gex-Fabry M, Eap CB, Oneda B, Gervasoni N, Aubry JM, Bondolfi G, Bertschy G.
    Ther Drug Monit; 2008 Aug; 30(4):474-82. PubMed ID: 18641553
    [Abstract] [Full Text] [Related]

  • 22. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A, Fouilloux C, Ortiz S.
    Proc West Pharmacol Soc; 2002 Aug; 45():154-5. PubMed ID: 12434564
    [No Abstract] [Full Text] [Related]

  • 23. The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients.
    Yokono A, Morita S, Someya T, Hirokane G, Okawa M, Shimoda K.
    J Clin Psychopharmacol; 2001 Dec; 21(6):549-55. PubMed ID: 11763000
    [Abstract] [Full Text] [Related]

  • 24. The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry.
    Chen S, Chou WH, Blouin RA, Mao Z, Humphries LL, Meek QC, Neill JR, Martin WL, Hays LR, Wedlund PJ.
    Clin Pharmacol Ther; 1996 Nov; 60(5):522-34. PubMed ID: 8941025
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot study.
    Rau T, Wohlleben G, Wuttke H, Thuerauf N, Lunkenheimer J, Lanczik M, Eschenhagen T.
    Clin Pharmacol Ther; 2004 May; 75(5):386-93. PubMed ID: 15116051
    [Abstract] [Full Text] [Related]

  • 28. Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers.
    Aarnoutse RE, Kleinnijenhuis J, Koopmans PP, Touw DJ, Wieling J, Hekster YA, Burger DM.
    Clin Pharmacol Ther; 2005 Dec; 78(6):664-74. PubMed ID: 16338282
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder.
    López-Ibor JJ, Saiz J, Cottraux J, Note I, Viñas R, Bourgeois M, Hernández M, Gómez-Pérez JC.
    Eur Neuropsychopharmacol; 1996 May; 6(2):111-8. PubMed ID: 8791036
    [Abstract] [Full Text] [Related]

  • 32. Cytochrome P450 2D6 phenoconversion is common in patients being treated for depression: implications for personalized medicine.
    Preskorn SH, Kane CP, Lobello K, Nichols AI, Fayyad R, Buckley G, Focht K, Guico-Pabia CJ.
    J Clin Psychiatry; 2013 Jun; 74(6):614-21. PubMed ID: 23541126
    [Abstract] [Full Text] [Related]

  • 33. Prevalence of patients using drugs metabolized by cytochrome P450 2D6 in different populations: a cross-sectional study.
    Mulder H, Heerdink ER, van Iersel EE, Wilmink FW, Egberts AC.
    Ann Pharmacother; 2007 Mar; 41(3):408-13. PubMed ID: 17341534
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Polymorphism in the metabolism of drugs, including antidepressant drugs: comments on phenotyping.
    Coutts RT.
    J Psychiatry Neurosci; 1994 Jan; 19(1):30-44. PubMed ID: 8148364
    [Abstract] [Full Text] [Related]

  • 36. CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly.
    Whyte EM, Romkes M, Mulsant BH, Kirshne MA, Begley AE, Reynolds CF, Pollock BG.
    Int J Geriatr Psychiatry; 2006 Jun; 21(6):542-9. PubMed ID: 16642541
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The effect of CYP2D6 polymorphisms on dextromethorphan metabolism in Mexican Americans.
    Casner PR.
    J Clin Pharmacol; 2005 Nov; 45(11):1230-5. PubMed ID: 16239355
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Extrapyramidal side effects of neuroleptic and antidepressant treatment: assessment of potential risk factors through CYP2D6 genetic polymorphism].
    Reggiani K, Vandel P, Haffen E, Sechter D, Bizouard P, Vandel S.
    Encephale; 2000 Nov; 26(1):62-7. PubMed ID: 10875063
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.